Messingerová, Lucia <br/><br/>
Lenalidomide treatment induced the normalization of marker protein levels in blood plasma of patients with 5q-myelodysplastic syndrome.  [electronic resource] 

 -  General physiology and biophysics  Oct 2015 
 - 399-406 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0231-5882 
<br/><br/><label>Standard No.: </label>10.4149/gpb_2015012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anemia, Macrocytic--blood<br/>Biomarkers--blood<br/>Blood Proteins--analysis<br/>Chromosome Deletion<br/>Chromosomes, Human, Pair 5<br/>Female<br/>Humans<br/>Immunologic Factors<br/>Lenalidomide<br/>Male<br/>Middle Aged<br/>Multidrug Resistance-Associated Proteins--blood<br/>Myelodysplastic Syndromes--blood<br/>Reproducibility of Results<br/>Sensitivity and Specificity<br/>Thalidomide--analogs & derivatives<br/>Treatment Outcome